Literature DB >> 28947930

Mitragyna speciosa: Balancing Potential Medical Benefits and Abuse.

Genevieve M Halpenny1.   

Abstract

Mitragyna speciosa, also known as kratom, has the potential meet the need for pain medications that lack the addictiveness and overdose risk of classical opioid analgesics, such as morphine. This need is urgent because opioid addiction and overdose deaths have risen throughout diverse segments of U.S. society. Some opioid addicts have found relief in kratom preparations. The use of kratom as an analgesic has been validated by historical accounts and contemporary pharmacological research. Although kratom is a promising source of analgesic candidates, it is a euphoriant with potential for both abuse and addiction. However, kratom appears to be less addictive and to have milder withdrawal symptoms than opioid drugs. Thus, there is a need to balance the potential medical benefits and abuse of M. speciosa.

Entities:  

Year:  2017        PMID: 28947930      PMCID: PMC5601368          DOI: 10.1021/acsmedchemlett.7b00298

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  7 in total

Review 1.  Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity.

Authors:  Jessica E Adkins; Edward W Boyer; Christopher R McCurdy
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

2.  Ethnopharmacology of kratom and the Mitragyna alkaloids.

Authors:  K L Jansen; C J Prast
Journal:  J Ethnopharmacol       Date:  1988 May-Jun       Impact factor: 4.360

3.  Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.

Authors:  András Váradi; Gina F Marrone; Travis C Palmer; Ankita Narayan; Márton R Szabó; Valerie Le Rouzic; Steven G Grinnell; Joan J Subrath; Evelyn Warner; Sanjay Kalra; Amanda Hunkele; Jeremy Pagirsky; Shainnel O Eans; Jessica M Medina; Jin Xu; Ying-Xian Pan; Attila Borics; Gavril W Pasternak; Jay P McLaughlin; Susruta Majumdar
Journal:  J Med Chem       Date:  2016-09-02       Impact factor: 7.446

4.  Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa).

Authors:  Friedrich G Kapp; Hans H Maurer; Volker Auwärter; Martin Winkelmann; Maren Hermanns-Clausen
Journal:  J Med Toxicol       Date:  2011-09

5.  Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.

Authors:  Andrew C Kruegel; Madalee M Gassaway; Abhijeet Kapoor; András Váradi; Susruta Majumdar; Marta Filizola; Jonathan A Javitch; Dalibor Sames
Journal:  J Am Chem Soc       Date:  2016-05-18       Impact factor: 15.419

Review 6.  Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa.

Authors:  Hiromitsu Takayama
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-08       Impact factor: 1.645

Review 7.  Orally active opioid compounds from a non-poppy source.

Authors:  Robert B Raffa; Jaclyn R Beckett; Vivek N Brahmbhatt; Theresa M Ebinger; Chrisjon A Fabian; Justin R Nixon; Steven T Orlando; Chintan A Rana; Ali H Tejani; Robert J Tomazic
Journal:  J Med Chem       Date:  2013-04-08       Impact factor: 7.446

  7 in total
  1 in total

1.  Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant.

Authors:  Alessandro E Vento; Simone de Persis; Sergio De Filippis; Fabrizio Schifano; Flavia Napoletano; John M Corkery; Georgios D Kotzalidis
Journal:  Front Psychiatry       Date:  2021-03-31       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.